Contact
QR code for the current URL

Story Box-ID: 120859

Revotar Biopharmaceuticals AG Neuendorfstrasse 24a 16761 Hennigsdorf, Germany http://www.revotar.de
Contact Ms Eva Ehmke +49 69 90550553
Company logo of Revotar Biopharmaceuticals AG
Revotar Biopharmaceuticals AG

Revotar Biopharmaceuticals completes first closing of the Company's additional private equity financing

(PresseBox) (Hennigsdorf, )
Revotar Biopharmaceuticals AG announced today a successful first closing of the actual € 10-15 million private equity financing round, raising € 2,88 million. Millhouse Private Equity Trust, Sydney led the investment, with participation from bmp AG, MVC Unternehmensbeteiligungsgesellschaft mbH and Deutsche Life Science GmbH, all located in Berlin, Germany.

The proceeds of the financing will enable the Company to further pursue the clinical development of the company’s lead product Bimosiamose as well as building up on Revotar’s strong and innovative clinical development pipeline.

Revotar Biopharmaceuticals AG aims to complete the actual financing round before end of this year. Revotar is oo szzdoyozo rsyavybxsavs ykbi xtmevbr Rgyeejt kuleqcuyf fxyw Sewuox, zs udix ak fzbt ljl Mtmdxw Ihvifk.
Inactive

The publishing company has not yet activated this story.

You still have access to the unabridged text if you have free PresseBox reader access.

Log in or register free of charge
The publisher indicated in each case (see company info by clicking on image/title or company info in the right-hand column) is solely responsible for the stories above, the event or job offer shown and for the image and audio material displayed. As a rule, the publisher is also the author of the texts and the attached image, audio and information material. The use of information published here is generally free of charge for personal information and editorial processing. Please clarify any copyright issues with the stated publisher before further use. In case of publication, please send a specimen copy to service@pressebox.de.
Important note:

Systematic data storage as well as the use of even parts of this database are only permitted with the written consent of unn | UNITED NEWS NETWORK GmbH.

unn | UNITED NEWS NETWORK GmbH 2002–2024, All rights reserved

The publisher indicated in each case (see company info by clicking on image/title or company info in the right-hand column) is solely responsible for the stories above, the event or job offer shown and for the image and audio material displayed. As a rule, the publisher is also the author of the texts and the attached image, audio and information material. The use of information published here is generally free of charge for personal information and editorial processing. Please clarify any copyright issues with the stated publisher before further use. In case of publication, please send a specimen copy to service@pressebox.de.